NASDAQ: ANEB - Anebulo Pharmaceuticals, Inc.

Yield per half year: -31.73%
Sector: Healthcare

Share chart Anebulo Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.000173
EV/EBITDA 16.29
IPO date 2021-05-07
ISIN US0345691036
Industry Biotechnology
P/BV 6.71
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.anebulo.com
Цена ао 2.6
Число акций ао 0.02507 млрд
Change price per day: +4.94% (1.62)
Change price per week: +71.72% (0.99)
Change price per month: +18.88% (1.43)
Change price per 3 month: -17.07% (2.05)
Change price per half year: -31.73% (2.49)
Change price per year: -29.75% (2.42)
Change price per 3 year: -74.63% (6.7)
Change price per 5 year: 0% (1.7)
Change price per 10 year: 0% (1.7)
Change price per year to date: +71.72% (0.99)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 18.96 1
P/E 0 0
EV/EBITDA -8.6 0
Total: 2.38

Efficiency

Title Value Grade
ROA, % -104.19 0
ROE, % -113.8 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 123.62 10
Yield EPS, % -75.49 0
Total: 3.6
More

Institutions Volume Share, %
22NW, LP 5366290 20.93
Nantahala Capital Management, LLC 1022146 3.99
LVW Advisors, LLC 643039 2.51
Morgan Stanley 399219 1.56
Ikarian Capital, LLC 157862 0.62
Vanguard Group Inc 153003 0.6
BOOTHBAY FUND MANAGEMENT, LLC 18978 0.07
Landscape Capital Management LLC 15000 0.06
Tower Research Capital LLC (TRC) 9102 0.04
Blackrock Inc. 4145 0.02

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.0012 11.9 1.54048



Head Job title Payment Year of birth
Dr. Joseph F. Lawler M.D., Ph.D. Founder & Chairman 11k 1972 (53 years)
Dr. Kenneth C. Cundy Ph.D. Chief Scientific Officer 425.15k 1959 (66 years)
Mr. Richard Anthony Cunningham CEO & Director N/A 1971 (54 years)
Mr. Daniel V. George Principal Accounting Officer, Acting CFO & Secretary N/A 1970 (55 years)

Address: United States, Lakeway. TX, 1017 Ranch Road 620 South - open in Google maps, open in Yandex maps
Website: https://www.anebulo.com